Alex Dale, Author at Labiotech.eu

About

A former journalist intern at Labiotech, Alex now works as a copywriter in healthcare advertising. When he’s not writing, he enjoys playing sports and long-distance cycling.

Articles by Alex Dale

News and Trends 17 Oct 2017

Genfit Gets €180M Cash Injection to Bring its Pipeline to Market

Elafibranor, Genfit’s lead candidate, will continue its march towards the market with the added boost of massive financial support. Genfit is a leader in the development of diagnostic tools and therapeutics for metabolic and inflammatory diseases. Its lead candidate, elafibranor, targets Non-Alcoholic Stato-Hepatitis (NASH) – an inflammatory disease of the liver. The company has raised €180M by selling bonds […]

October 17, 2017 - 3 minutesmins - By Alex Dale

dupilumab inflammation regeneron sanofi 1

News and Trends 16 Oct 2017

Biotech Power-Couple Sees Positive Phase II Results For Inflammatory Disease Drug

Regeneron and Sanofi’s drug, dupilumab, has met primary and secondary endpoints for the treatment of eosinophilic esophagitis. The biotech-biopharma giants have announced that their candidate, Dupilumab, demonstrated good efficacy during a Phase II trial. The drug is designed for use against eosinophilic esophagitis, a nasty inflammatory disease of the esophagus that makes it difficult to swallow. […]

October 16, 2017 - 3 minutesmins - By Alex Dale

antibiotic resistance inhibitor antabio 1

News and Trends 16 Oct 2017

French Biotech Lifted by €7M Series A to Develop New Antibiotics

Antabio has taken a step towards tackling antibiotic resistance by securing a €7.3M Series A. The funding will accelerate the company’s candidate through a Phase I clinical trial. Antabio is a French biopharma that focuses on one of the world’s biggest crises – antibiotic resistance. The company has raised €7.3M in Series A of fundraising, which it will use to […]

October 16, 2017 - 3 minutesmins - By Alex Dale

News and Trends 16 Oct 2017

New Stem Cells Could Take Cell Research and Therapies to the Next Level

British researchers have created a new type of stem cell in mice. It has even greater potential than current cell lines in research and in the clinic. Stem cells have huge potential in research and therapeutics and overcome the limitations of current cell lines – embryonic and induced pluripotent stem cells. Findings published in Nature report that researchers at […]

October 16, 2017 - 3 minutesmins - By Alex Dale

ResearchGate publishers copyright infringement

News and Trends 13 Oct 2017

Why Might Biotechs Lose Easy Access to Scientific Papers?

Five publishers have ordered ResearchGate to take down articles. Researchers might continue to get around the paywall with Sci-Hub and other initiatives. ResearchGate, described as ‘Facebook for scientists’, has over 13 million members. It has raised more than $80M (€68M) from investors including Bill Gates and the Wellcome Trust. But, five scientific publishers including Elsevier and Wiley have clubbed […]

October 13, 2017 - 3 minutesmins - By Alex Dale

Startup Scout 13 Oct 2017

This French Biotech is Taking On CNS Diseases of the Young and the Elderly

This week we’re in Castres in the South of France to visit Neurolixis. This biotech is taking on diseases of the CNS, such as Parkinson’s, depression and schizophrenia. Mission: Neurolixis is tackling CNS and mood diseases, a number of which lack effective treatment options at the moment. The biotech currently has two candidate drugs undergoing […]

October 13, 2017 - 2 minutesmins - By Alex Dale

News and Trends 12 Oct 2017

Deadly Parasite Could be Stopped by Scottish Researchers’ Discovery

A study in Scotland has improved our understanding of how a dangerous parasite functions, creating a new target for combatting deadly infections. Research from the University of Edinburgh has identified a therapeutic target in Leishmania, a parasite that infects 1 million people each year, resulting in 20,000-30,000 deaths. The study, published in the Journal of Molecular Biology, used clever […]

October 12, 2017 - 3 minutesmins - By Alex Dale

News and Trends 11 Oct 2017

Scottish Scientists Could Hold the Key to Unlocking Parkinson’s Disease

A decade of work has culminated in researchers reconstructing a protein that is key to defending the brain against Parkinson’s disease. Researchers at the University of Dundee have made a breakthrough by uncovering the 3D structure of an enzyme, PINK1, that can protect the brain against Parkinson’s disease. The disease is characterised by the degeneration […]

October 11, 2017 - 3 minutesmins - By Alex Dale

News and Trends 10 Oct 2017

Market Ready HIV Self-Test Gets the Thumbs Up from the European Union

Technology allowing individuals to accurately test themselves for HIV has received a CE Mark from the EU, meaning it can soon be released onto the market. The EU has awarded a CE Mark to an HIV self-test, developed by world-leading diagnostics developer, Atomo Diagnostics, Sydney, Australia. The world’s first at-home device detects the presence of Human Immunodeficiency Virus […]

October 10, 2017 - 3 minutesmins - By Alex Dale

Best in Biotech 10 Oct 2017

Buongiorno Biotech! Top 4 Companies Making Milan Europe’s Next Biotech Hub

Italy may not be the first country that comes to mind when you think of biotech, but the sun is rising in a new dawn for Italian biotechs that are taking their respective fields by storm. Italy is home to a lot of things; food, fashion, Ferraris… but it is now quickly growing a biotech scene […]

October 10, 2017 - 7 minutesmins - By Alex Dale

More News! 10 Oct 2017

Update: Finnish Biotech to Raise £10M for Rare Lung Disease Drug

Update (10/10/2017): Faron Pharmaceuticals’ fundraising has been

October 10, 2017 - 1 minutemin - By Alex Dale

News and Trends 9 Oct 2017

British Scientists Regenerate Bone By Mimicking Nature

Nano-sized vesicles that are generated naturally during bone formation have the potential to regenerate bone, teeth and cartilage. Researchers from the University of Birmingham have mimicked the body’s natural healing process to repair damaged tissue, for example, bone. The study, which is published in Scientific Reports, has found that vesicles produced by stimulated cells outperform the […]

October 9, 2017 - 3 minutesmins - By Alex Dale

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Alex Dale

About

Articles by Alex Dale

Genfit Gets €180M Cash Injection to Bring its Pipeline to Market

Biotech Power-Couple Sees Positive Phase II Results For Inflammatory Disease Drug

French Biotech Lifted by €7M Series A to Develop New Antibiotics

New Stem Cells Could Take Cell Research and Therapies to the Next Level

Why Might Biotechs Lose Easy Access to Scientific Papers?

This French Biotech is Taking On CNS Diseases of the Young and the Elderly

Deadly Parasite Could be Stopped by Scottish Researchers’ Discovery

Scottish Scientists Could Hold the Key to Unlocking Parkinson’s Disease

Market Ready HIV Self-Test Gets the Thumbs Up from the European Union

Buongiorno Biotech! Top 4 Companies Making Milan Europe’s Next Biotech Hub

Update: Finnish Biotech to Raise £10M for Rare Lung Disease Drug

British Scientists Regenerate Bone By Mimicking Nature

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Alex Dale

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!